CNBX Pharmaceuticals Inc (CNBX)

[jim992]

This posted 10/25/17 at Etrade regarding patents, etc:

Biotechs Develop Proprietary Systems to Drive CBD -2-

Oct 25, 2017 08:30:00 (ET)

NetworkNewsWire Editorial Coverage

NEW YORK, October 25, 2017 /PRNewswire/ --

Cannabics Pharmaceuticals (OTCQB: CNBX) provides diagnostic tools and bioinformatics to support practitioners and patients.

Also engaged in scientific and clinical research through its subsidiary, Grin Ultra, the company is developing cannabinoid-based medicine for cancer patients, examining efficacy through in-vitro studies and clinical trials.

Cannabics is currently studying the effect of its proprietary cannabis capsules on weight and appetite loss in cancer patients.

The company recently filed national phase patent applications for its proprietary cannabis-based cancer cell screening technology in the United States, Canada, Europe, Australia, China, India and Brazil.